Abiopharma

🔍 Burke Carolyn Jeanne (Executive)

Company: PG&E Corp (PCG)

Report Date: 2026-03-16

Detailed Transactions and Holdings:

• Acquired 144,806 shares of Common Stock (Direct)
  Date: 2026-03-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 229,560.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 80,049 shares of Common Stock at $18.14 per share (Direct)
  Date: 2026-03-16 | Code: F | equity_swap_involved: 0 | shares_owned_after: 149,511.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Vested performance shares granted under the PG&E Corporation 2021 Long-Term Incentive Plan for the performance cycle ended 12/31/2025. Performance shares are payable in shares of PG&E Corporation common stock on a one-for-one basis.
• F2: These shares were forfeited to satisfy tax withholding obligations in connection with the vesting of performance share units.